These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26644118)

  • 21. Bisphosphonates for Paget's disease of bone in adults.
    Corral-Gudino L; Tan AJ; Del Pino-Montes J; Ralston SH
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD004956. PubMed ID: 29192423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral bisphosphonates and risk of ischemic stroke: a case-control study.
    Christensen S; Mehnert F; Chapurlat RD; Baron JA; Sørensen HT
    Osteoporos Int; 2011 Jun; 22(6):1773-9. PubMed ID: 20945149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database.
    Khalid S; Calderon-Larranaga S; Sami A; Hawley S; Judge A; Arden N; Van Staa TP; Cooper C; Abrahamsen B; Javaid MK; Prieto-Alhambra D
    Osteoporos Int; 2022 Jul; 33(7):1579-1589. PubMed ID: 35138412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reports of esophageal cancer with oral bisphosphonate use.
    Wysowski DK
    N Engl J Med; 2009 Jan; 360(1):89-90. PubMed ID: 19118315
    [No Abstract]   [Full Text] [Related]  

  • 25. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers.
    Vogtmann E; Corley DA; Almers LM; Cardwell CR; Murray LJ; Abnet CC
    PLoS One; 2015; 10(10):e0140180. PubMed ID: 26445463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Use of Bisphosphonates with Risk of Breast Cancer: A Meta-Analysis.
    Peng R; Liang X; Zhang G; Yao Y; Chen Z; Pan X; Wang J; Liu G
    Biomed Res Int; 2020; 2020():5606573. PubMed ID: 33102580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of serious atrial fibrillation and stroke with use of bisphosphonates: evidence from a meta-analysis.
    Sharma A; Chatterjee S; Arbab-Zadeh A; Goyal S; Lichstein E; Ghosh J; Aikat S
    Chest; 2013 Oct; 144(4):1311-1322. PubMed ID: 23722644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exposure to oral bisphosphonates and risk of gastrointestinal cancer.
    Choi D; Choi S; Chang J; Park SM
    Osteoporos Int; 2020 Apr; 31(4):775-782. PubMed ID: 32034451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart failure in patients treated with bisphosphonates.
    Grove EL; Abrahamsen B; Vestergaard P
    J Intern Med; 2013 Oct; 274(4):342-50. PubMed ID: 23679231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bisphosphonate adverse effects, lessons from large databases.
    Abrahamsen B
    Curr Opin Rheumatol; 2010 Jul; 22(4):404-9. PubMed ID: 20473174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study.
    Herrera L; Leal I; Lapi F; Schuemie M; Arcoraci V; Cipriani F; Sessa E; Vaccheri A; Piccinni C; Staniscia T; Vestri A; Di Bari M; Corrao G; Zambon A; Gregori D; Carle F; Sturkenboom M; Mazzaglia G; Trifiro G
    Osteoporos Int; 2015 May; 26(5):1499-506. PubMed ID: 25752621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies.
    Mak A; Cheung MW; Ho RC; Cheak AA; Lau CS
    BMC Musculoskelet Disord; 2009 Sep; 10():113. PubMed ID: 19772579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of bisphosphonates.
    Orozco C; Maalouf NM
    Rheum Dis Clin North Am; 2012 Nov; 38(4):681-705. PubMed ID: 23137577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.
    Tadrous M; Wong L; Mamdani MM; Juurlink DN; Krahn MD; Lévesque LE; Cadarette SM
    Osteoporos Int; 2014 Apr; 25(4):1225-35. PubMed ID: 24287510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between bisphosphonate use and stroke risk: a meta-analysis.
    Lin SM; Lin JY; Tu YK; Wu CH; Peng CC; Munir KM; Bukhari K; Jaggon K; Fu Y; Loh CH; Huang HK
    Osteoporos Int; 2023 Sep; 34(9):1625-1636. PubMed ID: 37249610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal Trends and Factors Associated with Bisphosphonate Discontinuation and Restart.
    Adami G; Jaleel A; Curtis JR; Delzell E; Chen R; Yun H; Daigle S; Arora T; Danila MI; Wright NC; Cadarette SM; Mudano A; Foster J; Saag KG
    J Bone Miner Res; 2020 Mar; 35(3):478-487. PubMed ID: 31714637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bisphosphonates and their influence on fracture healing: a systematic review.
    Molvik H; Khan W
    Osteoporos Int; 2015 Apr; 26(4):1251-60. PubMed ID: 25572046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the impact of bisphosphonate therapy upon dental implant survival? A systematic review and meta-analysis.
    Ata-Ali J; Ata-Ali F; Peñarrocha-Oltra D; Galindo-Moreno P
    Clin Oral Implants Res; 2016 Feb; 27(2):e38-46. PubMed ID: 25406770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisphosphonate use and the risk of breast cancer: a meta-analysis of published literature.
    Liu Y; Zhao S; Chen W; Hu F; Zhu L; Zhang Q; Zhao Y
    Clin Breast Cancer; 2012 Aug; 12(4):276-81. PubMed ID: 22622199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.